Vnitr Lek 2020, 66(3):e41-e43 | DOI: 10.36290/vnl.2020.058
Arterial hypertension and COVID-19 infections: A brief commentary
- Centrum pro hypertenzi, III. interní klinika VFN a 1. LF UK Praha
The issue of hypertension/antihypertensive treatment in patients with COVID-19 infection is discussed in the commentary.
Keywords: hypertension, antihypertensive drugs, COVID-19.
Published: May 26, 2020 Show citation
References
- Danser J, Epstein M, Batlle Renin‑Angiotensin D. System Blockers and the COVID-19 Pandemic At Present There Is No Evidence to Abandon Renin‑Angiotensin System Blockers. Hypertension June 2020/ DOI: 10.1161/HYPERTENSIONAHA.120.15082.
Go to original source...
Go to PubMed...
- Esler M, Esler D. Can angiotensin receptor‑blocking drug perhaps be harmful in the COVID-19 pandemic? J Hypertension, 2020, 38, 781-782.
Go to original source...
Go to PubMed...
- Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, Clement DL, Coca A, de Simone G, Dominiczak A, Kahan T, Mahfoud F, Redon J, Ruilope L, Zanchetti A, Kerins M, Kjeldsen SE, Kreutz R, Laurent S, Lip GYH, McManus R, Narkiewicz K, Ruschitzka F, Schmieder RE, Shlyakhto E, Tsioufis C, Aboyans V and Desormais I. 2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension. Journal of hypertension. 2018; 36: 1953-2041.
Go to original source...
Go to PubMed...
- Diagnostické a léčebné postupy u arteriální hypertenze - verze 2017. Doporučení České společnosti pro hypertenzi J. Widimský jr., J. Filipovský, J. Ceral, R. Cífková, A. Linhart, V. Monhart, H. Rosolová, J. Seidlerová Mlíková, M. Souček, J. ©pinar, V.Tesař, J. Vítovec T. Zelinka. Hypertenze a kardiovaskulární prevence, 2018, supplement, str. 1-22.